Tumor-Associated Macrophage-Induced Invasion and Angiogenesis of Human Basal Cell Carcinoma Cells by Cyclooxygenase-2 Induction

被引:288
作者
Tjiu, Jeng-Wei [1 ]
Chen, Jau-Shiuh [1 ]
Shun, Chia-Tung [2 ,3 ]
Lin, Sung-Jan [1 ]
Liao, Yi-Hua [1 ]
Chu, Chia-Yu [1 ]
Tsai, Tsen-Fang [1 ]
Chiu, Hsien-Ching [1 ]
Dai, Yang-Shia [1 ]
Inoue, Hiroyasu [4 ]
Yang, Pan-Chyr [5 ]
Kuo, Min-Liang [6 ]
Jee, Shiou-Hwa [1 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Forens Med, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan
[4] Nara Womens Univ, Dept Food Sci & Nutr, Nara 630, Japan
[5] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[6] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Lab Mol & Cellular Toxicol, Taipei, Taiwan
关键词
FIBROBLAST-GROWTH-FACTOR; NF-KAPPA-B; INFILTRATING MACROPHAGES; BREAST-CANCER; UP-REGULATION; SKIN-CANCER; EXPRESSION; PROGRESSION; POLARIZATION; ACTIVATION;
D O I
10.1038/jid.2008.310
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Tumor-associated macrophages (TAMs) and cyclooxygenase-2 (COX-2) are associated with invasion, angiogenesis, and poor prognosis in many human cancers. However, the role of TAMs in human basal cell carcinoma (BCC) remains elusive. We found that the number of TAMs infiltrating the tumor is correlated with the depth of invasion, microvessel density, and COX-2 expression in human BCC cells. TAMs also aggregate near COX-2 expressing BCC tumor nests. We hypothesize that TAMs might activate COX-2 in BCC cells and subsequently increase their invasion and angiogenesis. TAMs are a kind of M2 macrophage derived from macrophages exposed to Th2 cytokines. M2-polarized macrophages derived from peripheral blood monocytes were cocultured with BCC cells without direct contact. Coculture with the M2 macrophages induced COX-2-dependent invasion and angiogenesis of BCC cells. Human THP-1 cell line cells, after treated with phorbol myristate acetate (PMA), differentiated to macrophages with M2 functional profiles. Coculture with PMA-treated THP-1 macrophages induced COX-2-dependent release of matrix metalloproteinase-9 and subsequent increased invasion of BCC cells. Macrophages also induced COX-2-dependent secretion of basic fibroblast growth factor and vascular endothelial growth factor-A, and increased angiogenesis in BCC cells.
引用
收藏
页码:1016 / 1025
页数:10
相关论文
共 27 条
[21]   Expression of basic fibroblast growth factor, vascular endothelial growth factor, and thrombospondin-1 related to microvessel density in nonaggressive and aggressive basal cell carcinomas [J].
Oh, CK ;
Kwon, YW ;
Kim, YS ;
Jang, HS ;
Kwon, KS .
JOURNAL OF DERMATOLOGY, 2003, 30 (04) :306-313
[22]   Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy [J].
Sica, A ;
Schioppa, T ;
Mantovani, A ;
Allavena, P .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (06) :717-727
[23]   Cyclooxygenase-2 overexpression in human basal cell carcinoma cell line increases antiapoptosis, angiogenesis, and tumorigenesis [J].
Tjiu, Jeng-Wei ;
Liao, Yi-Hua ;
Lin, Sung-Jan ;
Huang, Yi-Ling ;
Tsai, Wei-Ling ;
Chu, Chia-Yu ;
Kuo, Min-Liang ;
Jee, Shiou-Hwa .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (05) :1143-1151
[24]   Aggressive basal cell carcinoma: Presentation, pathogenesis, and management [J].
Walling, HW ;
Fosko, SW ;
Geraminejad, PA ;
Whitaker, DC ;
Arpey, CJ .
CANCER AND METASTASIS REVIEWS, 2004, 23 (3-4) :389-402
[25]   Cycloxygeroase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer [J].
Wang, WZ ;
Bergh, A ;
Damber, JE .
CLINICAL CANCER RESEARCH, 2005, 11 (09) :3250-3256
[26]   IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo [J].
Watkins, Stephanie K. ;
Egilmez, Nejat K. ;
Suttles, Jill ;
Stout, Robert D. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (03) :1357-1362
[27]   Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod [J].
Wenzel, J ;
Uerlich, M ;
Haller, O ;
Bieber, T ;
Tueting, T .
JOURNAL OF CUTANEOUS PATHOLOGY, 2005, 32 (04) :257-262